EUVIMEDEUVIMED entdecken
Fallbericht

Excellent Long‐Term Outcome in a Staged, Simultaneous Liver‐Kidney Transplantation of a Highly Sensitized Pediatric Patient With B and T Cell Positive Crossmatch

Margret Bock iD, Eric Benz iD, Eliza Blanchette iD, Jens Goebel iD, Gina Wedermyer iD, Christina Roark iD, Michael Wachs iD, Megan Adams iD, Shikha Sundaram iD, Mary Chandran iD

Pediatric Transplantation · 2026-11 · 30 (11)

DOI: 10.1111/petr.70514 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Transplantation, online erschienen am 01.11.2026. Verfasst von Margret Bock und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Nephrology, Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Kidney Transplantation, T-Lymphocytes, B-Lymphocytes. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While immunologically challenging and controversial, we report a successful case of same donor staged simultaneous liver‐kidney transplant (SLK) in a highly sensitized small child against a positive cytotoxic crossmatch (XM) and high Class I/II donor‐specific antibody (DSA) titers.

Methods

Our immunologic approach included: Rituximab given prior to liver transplant (LT) and Methylprednisone and Basiliximab during the anhepatic phase. A flow XM obtained 30 min after LT was negative for T cell flow, while B cell flow remained positive, presumably related to Rituximab. The donor kidney was pumped overnight. Tacrolimus (Tac) and Cellcept (MMF) were initiated.

Results

On return to the operating room 18 h later, the T cell flow XM was negative, and the B cell flow XM was weakly positive. Eculuzimab and MP were given at renal graft perfusion. Immediate urine output occurred. Normalization of liver and kidney markers was noted. At 5 years post staged SLK, there is excellent liver and kidney function and no evidence of de‐novo DSA. Interestingly, non‐HLA antibody mediated rejection of the liver only was observed 1 year post transplant.

Conclusions

We present the successful staged SLK of a complex, highly sensitized child in the setting of high titers of Class I/II DSAs against positive XMs. Sophisticated immunologic management and delay of kidney transplantation by 18 h, presumably allowing the liver allograft to absorb circulating DSAs and T‐cells, resulted in excellent short and long‐term graft function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationKidney TransplantationT-LymphocytesB-LymphocytesHumansImmunosuppressive AgentsTreatment OutcomeHistocompatibility TestingMaleFemaleChildGraft Rejection

Stichwörter der Autor:innen

autosomal recessive polycystic kidney diseasepediatricpositive crossmatchsensitizationsimultaneous liver kidney transplantation

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Section of Nephrology, Department of Pediatrics, School of Medicine and Public Health, University of Wisconsin Madison, Madison, Wisconsin, USA.
  • Section of Nephrology, Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado, USA.
  • Section of Nephrology, Department of Pediatrics, Michigan State University, Grand Rapids, Michigan, USA.
  • Clinimmune Center for Clinical Immunology, Aurora, Colorado, USA.
  • Division of Abdominal Transplantation, Department of Surgery, School of Medicine, University of Colorado, Aurora, Colorado, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, School of Medicine, University of Colorado, Aurora, Colorado, USA.

ORCID-Profile: Margret Bock, Eric Benz, Eliza Blanchette, Jens Goebel, Gina Wedermyer, Christina Roark, Michael Wachs, Megan Adams, Shikha Sundaram, Mary Chandran

Zitieren

APA

Bock, M., Benz, E., Blanchette, E., Goebel, J., Wedermyer, G., Roark, C., Wachs, M., Adams, M., Sundaram, S., & Chandran, M. (2026). Excellent Long‐Term Outcome in a Staged, Simultaneous Liver‐Kidney Transplantation of a Highly Sensitized Pediatric Patient With B and T Cell Positive Crossmatch. Pediatric Transplantation, 30(11). https://doi.org/10.1111/petr.70514

Vancouver

Bock M, Benz E, Blanchette E, Goebel J, Wedermyer G, Roark C, et al. Excellent Long‐Term Outcome in a Staged, Simultaneous Liver‐Kidney Transplantation of a Highly Sensitized Pediatric Patient With B and T Cell Positive Crossmatch. Pediatric Transplantation. 2026;30(11). doi:10.1111/petr.70514

BibTeX
@article{Bock2026,
  author = {Bock, Margret and Benz, Eric and Blanchette, Eliza and Goebel, Jens and Wedermyer, Gina and Roark, Christina and Wachs, Michael and Adams, Megan and Sundaram, Shikha and Chandran, Mary},
  title = {Excellent Long‐Term Outcome in a Staged, Simultaneous Liver‐Kidney Transplantation of a Highly Sensitized Pediatric Patient With B and T Cell Positive Crossmatch},
  journal = {Pediatric Transplantation},
  year = {2026},
  volume = {30},
  number = {11},
  doi = {10.1111/petr.70514}
}
Kostenlos starten →